blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3006041

EP3006041 - METHODS FOR PREPARING COMPLEX MULTIVALENT IMMUNOGENIC CONJUGATES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.10.2018
Database last updated on 07.10.2024
FormerThe patent has been granted
Status updated on  27.10.2017
FormerGrant of patent is intended
Status updated on  18.10.2017
FormerRequest for examination was made
Status updated on  19.09.2017
FormerGrant of patent is intended
Status updated on  03.05.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
The Government of the United States of America, as represented by The Secretary, Department of Health and Human Services
The National Institute of Health
Office of Technology Transfer
6011 Executive Boulvard, Suite 325
Rockville, MD 20852 / US
[2016/15]
Inventor(s)01 / LEE, Che-Hung Robert
16 Amberleigh Drive
Silver Spring, MD 20905 / US
 [2016/15]
Representative(s)Gowshall, Jonathan Vallance
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[2017/48]
Former [2016/15]Gowshall, Jonathan Vallance
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Application number, filing date15195219.916.03.2007
[2016/15]
Priority number, dateUS20060783490P17.03.2006         Original published format: US 783490 P
[2016/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3006041
Date:13.04.2016
Language:EN
[2016/15]
Type: B1 Patent specification 
No.:EP3006041
Date:29.11.2017
Language:EN
[2017/48]
Search report(s)(Supplementary) European search report - dispatched on:EP14.03.2016
ClassificationIPC:A61K39/385, A61K39/08, A61K39/095, A61K39/00, C07K1/08, A61K39/116
[2017/17]
CPC:
A61K39/385 (EP,KR,US); C07K1/084 (EP,KR,US); A61K39/08 (KR);
A61K39/095 (KR); A61K39/116 (EP,KR,US); A61K47/50 (KR);
A61K47/6415 (EP,KR,US); A61K47/646 (EP,KR,US); A61P31/04 (EP,KR);
A61P37/04 (EP); A61K2039/6037 (EP,KR,US); A61K2039/62 (EP,KR,US);
Y02A50/30 (EP,US) (-)
Former IPC [2016/15]A61K39/385, A61K39/08, A61K39/095, A61K39/00, A61K47/48
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/15]
TitleGerman:VERFAHREN ZUM HERSTELLEN KOMPLEXER MEHRWERTIGER IMMUNOGENER KONJUGATE[2016/15]
English:METHODS FOR PREPARING COMPLEX MULTIVALENT IMMUNOGENIC CONJUGATES[2016/15]
French:PROCÉDÉ DE PRÉPARATION DE CONJUGUÉS IMMUNOGÉNIQUES MULTIVALENTS COMPLEXES[2016/15]
Examination procedure18.11.2015Examination requested  [2016/15]
12.10.2016Amendment by applicant (claims and/or description)
04.05.2017Communication of intention to grant the patent
04.09.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.09.2017Fee for grant paid
04.09.2017Fee for publishing/printing paid
18.10.2017Information about intention to grant a patent
18.10.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07753268.7  / EP1993604
Opposition(s)30.08.2018No opposition filed within time limit [2018/45]
Fees paidRenewal fee
18.11.2015Renewal fee patent year 03
18.11.2015Renewal fee patent year 04
18.11.2015Renewal fee patent year 05
18.11.2015Renewal fee patent year 06
18.11.2015Renewal fee patent year 07
18.11.2015Renewal fee patent year 08
18.11.2015Renewal fee patent year 09
31.03.2016Renewal fee patent year 10
27.03.2017Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.03.2007
AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
PT29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
TR29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
MT16.03.2018
IS29.03.2018
BE31.03.2018
CH31.03.2018
LI31.03.2018
[2020/33]
Former [2020/30]HU16.03.2007
AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
PT29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
TR29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
MT16.03.2018
BE31.03.2018
CH31.03.2018
LI31.03.2018
Former [2020/28]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
PT29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
TR29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
MT16.03.2018
BE31.03.2018
CH31.03.2018
LI31.03.2018
Former [2020/16]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
TR29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
MT16.03.2018
BE31.03.2018
CH31.03.2018
LI31.03.2018
Former [2020/08]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
MT16.03.2018
BE31.03.2018
CH31.03.2018
LI31.03.2018
Former [2019/12]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
BE31.03.2018
CH31.03.2018
LI31.03.2018
Former [2019/09]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
IE16.03.2018
LU16.03.2018
Former [2019/04]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
LU16.03.2018
Former [2018/52]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
MC29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SI29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/41]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
NL29.11.2017
PL29.11.2017
RO29.11.2017
SE29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/39]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
IT29.11.2017
LT29.11.2017
LV29.11.2017
NL29.11.2017
PL29.11.2017
SE29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/37]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
LT29.11.2017
LV29.11.2017
NL29.11.2017
PL29.11.2017
SE29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/35]AT29.11.2017
CY29.11.2017
CZ29.11.2017
DK29.11.2017
EE29.11.2017
ES29.11.2017
FI29.11.2017
LT29.11.2017
LV29.11.2017
NL29.11.2017
SE29.11.2017
SK29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/34]AT29.11.2017
DK29.11.2017
ES29.11.2017
FI29.11.2017
LT29.11.2017
LV29.11.2017
NL29.11.2017
SE29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/24]AT29.11.2017
ES29.11.2017
FI29.11.2017
LT29.11.2017
LV29.11.2017
SE29.11.2017
BG28.02.2018
GR01.03.2018
Former [2018/23]AT29.11.2017
ES29.11.2017
FI29.11.2017
LT29.11.2017
SE29.11.2017
GR01.03.2018
Former [2018/22]ES29.11.2017
FI29.11.2017
LT29.11.2017
Documents cited:Search[XY]WO02058737  (AVENTIS PASTEUR [US], et al);
 [AD]US2005002948  (RYALL ROBERT P [US]);
 [XY]WO2005037320  (US GOV HEALTH & HUMAN SERV [US], et al);
 [A]WO2005117965  (US GOV HEALTH & HUMAN SERV [US], et al);
 [XP]WO2006077397  (AMURA THERAPEUTICS LTD [GB], et al);
by applicantUS5651971
 US5965714
 WO0004922
 WO02058737
 WO03007985
 US2005002948
 WO2005014037
 WO2005037320
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.